Investor mix
4 investors on record; lead investors include Horowitz Group.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 50% |
| Other / undisclosed | 2 | 50% |
Developer of a therapeutic device for peripheral arterial disease
4 investors on record; lead investors include Horowitz Group.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 50% |
| Other / undisclosed | 2 | 50% |